ID   TMM43_HUMAN             Reviewed;         400 AA.
AC   Q9BTV4; Q7L4N5; Q8NC30; Q96A63; Q96F19; Q96JX0; Q9H076;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   18-JUN-2025, entry version 175.
DE   RecName: Full=Transmembrane protein 43;
DE   AltName: Full=Protein LUMA;
GN   Name=TMEM43; ORFNames=UNQ2564/PRO6244;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASN-168 AND THR-179.
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASN-168 AND THR-179.
RC   TISSUE=Placenta, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASN-168 AND THR-179.
RC   TISSUE=Brain, Ovary, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=18230648; DOI=10.1242/jcs.019281;
RA   Bengtsson L., Otto H.;
RT   "LUMA interacts with emerin and influences its distribution at the inner
RT   nuclear membrane.";
RL   J. Cell Sci. 121:536-548(2008).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   INTERACTION WITH SUN2, VARIANTS EDMD7 LYS-85 AND VAL-91, AND
RP   CHARACTERIZATION OF VARIANTS EDMD7 LYS-85 AND VAL-91.
RX   PubMed=21391237; DOI=10.1002/ana.22338;
RA   Liang W.C., Mitsuhashi H., Keduka E., Nonaka I., Noguchi S., Nishino I.,
RA   Hayashi Y.K.;
RT   "TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy.";
RL   Ann. Neurol. 69:1005-1013(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH CARD10.
RX   PubMed=27991920; DOI=10.1038/onc.2016.430;
RA   Jiang C., Zhu Y., Zhou Z., Gumin J., Bengtsson L., Wu W., Songyang Z.,
RA   Lang F.F., Lin X.;
RT   "TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-kappaB
RT   activation and tumor progression.";
RL   Oncogene 36:2813-2823(2017).
RN   [14]
RP   FUNCTION, INTERACTION WITH RNF26, AND SUBCELLULAR LOCATION.
RX   PubMed=32614325; DOI=10.7554/elife.57306;
RA   Fenech E.J., Lari F., Charles P.D., Fischer R., Laetitia-Thezenas M.,
RA   Bagola K., Paton A.W., Paton J.C., Gyrd-Hansen M., Kessler B.M.,
RA   Christianson J.C.;
RT   "Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies
RT   modulators of innate immune signalling.";
RL   Elife 9:0-0(2020).
RN   [15]
RP   VARIANT ARVD5 LEU-358.
RX   PubMed=18313022; DOI=10.1016/j.ajhg.2008.01.010;
RA   Merner N.D., Hodgkinson K.A., Haywood A.F.M., Connors S., French V.M.,
RA   Drenckhahn J.-D., Kupprion C., Ramadanova K., Thierfelder L., McKenna W.,
RA   Gallagher B., Morris-Larkin L., Bassett A.S., Parfrey P.S., Young T.-L.;
RT   "Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully
RT   penetrant, lethal arrhythmic disorder caused by a missense mutation in the
RT   TMEM43 gene.";
RL   Am. J. Hum. Genet. 82:809-821(2008).
RN   [16]
RP   ACETYLATION AT ALA-2.
RX   PubMed=25732826; DOI=10.1016/j.celrep.2015.01.053;
RA   Aksnes H., Van Damme P., Goris M., Starheim K.K., Marie M., Stoeve S.I.,
RA   Hoel C., Kalvik T.V., Hole K., Glomnes N., Furnes C., Ljostveit S.,
RA   Ziegler M., Niere M., Gevaert K., Arnesen T.;
RT   "An organellar nalpha-acetyltransferase, naa60, acetylates cytosolic N
RT   termini of transmembrane proteins and maintains Golgi integrity.";
RL   Cell Rep. 10:1362-1374(2015).
RN   [17]
RP   INVOLVEMENT IN AUNA3, VARIANT AUNA3 372-ARG--GLU-400 DEL, CHARACTERIZATION
RP   OF VARIANT AUNA3 372-ARG--GLU-400 DEL, FUNCTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH GJB2 AND GJB4.
RX   PubMed=34050020; DOI=10.1073/pnas.2019681118;
RA   Jang M.W., Oh D.Y., Yi E., Liu X., Ling J., Kim N., Sharma K., Kim T.Y.,
RA   Lee S., Kim A.R., Kim M.Y., Kim M.A., Lee M., Han J.H., Han J.J.,
RA   Park H.R., Kim B.J., Lee S.Y., Woo D.H., Oh J., Oh S.J., Du T., Koo J.W.,
RA   Oh S.H., Shin H.W., Seong M.W., Lee K.Y., Kim U.K., Shin J.B., Sang S.,
RA   Cai X., Mei L., He C., Blanton S.H., Chen Z.Y., Chen H., Liu X.,
RA   Nourbakhsh A., Huang Z., Kang K.W., Park W.Y., Feng Y., Lee C.J.,
RA   Choi B.Y.;
RT   "A nonsense TMEM43 variant leads to disruption of connexin-linked function
RT   and autosomal dominant auditory neuropathy spectrum disorder.";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
CC   -!- FUNCTION: May have an important role in maintaining nuclear envelope
CC       structure by organizing protein complexes at the inner nuclear
CC       membrane. Required for retaining emerin at the inner nuclear membrane
CC       (By similarity). Plays a role in the modulation of innate immune
CC       signaling through the cGAS-STING pathway by interacting with RNF26
CC       (PubMed:32614325). In addition, functions as a critical signaling
CC       component in mediating NF-kappa-B activation by acting downstream of
CC       EGFR and upstream of CARD10 (PubMed:27991920). Contributes to passive
CC       conductance current in cochlear glia-like supporting cells, mediated by
CC       gap junctions and necessary for hearing and speech discrimination
CC       (PubMed:34050020). {ECO:0000250|UniProtKB:Q9DBS1,
CC       ECO:0000269|PubMed:27991920, ECO:0000269|PubMed:32614325,
CC       ECO:0000269|PubMed:34050020}.
CC   -!- SUBUNIT: Can form oligomers through the transmembrane domains.
CC       Interacts with EMD; the interaction retains EMD at the inner nuclear
CC       membrane. Interacts with LMNA and LMNB2 (By similarity). Interacts with
CC       SUN2. Interacts with RNF26; this interaction is important to modulate
CC       innate immune signaling through the cGAS-STING pathway
CC       (PubMed:32614325). Interacts with CARD10 (PubMed:27991920). Interacts
CC       with gap junctions proteins GJB2/Cx26 and GJB4/Cx30 (PubMed:34050020).
CC       {ECO:0000250, ECO:0000269|PubMed:21391237, ECO:0000269|PubMed:27991920,
CC       ECO:0000269|PubMed:32614325, ECO:0000269|PubMed:34050020}.
CC   -!- INTERACTION:
CC       Q9BTV4; Q6Q788: APOA5; NbExp=3; IntAct=EBI-721293, EBI-3936819;
CC       Q9BTV4; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-721293, EBI-11343438;
CC       Q9BTV4; Q8N5K1: CISD2; NbExp=3; IntAct=EBI-721293, EBI-1045797;
CC       Q9BTV4; P50402: EMD; NbExp=5; IntAct=EBI-721293, EBI-489887;
CC       Q9BTV4; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-721293, EBI-18304435;
CC       Q9BTV4; P02671-2: FGA; NbExp=3; IntAct=EBI-721293, EBI-9640259;
CC       Q9BTV4; Q14318: FKBP8; NbExp=3; IntAct=EBI-721293, EBI-724839;
CC       Q9BTV4; Q96HH9: GRAMD2B; NbExp=6; IntAct=EBI-721293, EBI-2832937;
CC       Q9BTV4; P42858: HTT; NbExp=3; IntAct=EBI-721293, EBI-466029;
CC       Q9BTV4; Q9Y5K3-3: PCYT1B; NbExp=3; IntAct=EBI-721293, EBI-12280028;
CC       Q9BTV4; P11684: SCGB1A1; NbExp=3; IntAct=EBI-721293, EBI-7797649;
CC       Q9BTV4; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-721293, EBI-747107;
CC       Q9BTV4; Q8IUQ4-2: SIAH1; NbExp=3; IntAct=EBI-721293, EBI-11522811;
CC       Q9BTV4; Q9H7V2: SYNDIG1; NbExp=3; IntAct=EBI-721293, EBI-726331;
CC       Q9BTV4; Q9BTV4: TMEM43; NbExp=4; IntAct=EBI-721293, EBI-721293;
CC       Q9BTV4; Q9UHP3: USP25; NbExp=3; IntAct=EBI-721293, EBI-2513462;
CC       Q9BTV4; Q6PEW1: ZCCHC12; NbExp=3; IntAct=EBI-721293, EBI-748373;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:32614325}. Nucleus inner membrane; Multi-pass
CC       membrane protein. Cell membrane {ECO:0000269|PubMed:34050020}.
CC       Note=Retained in the inner nuclear membrane through interaction with
CC       EMD and A- and B-lamins. The N- and C-termini are oriented towards the
CC       nucleoplasm. The majority of the hydrophilic domain resides in the
CC       endoplasmic reticulum lumen (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highest expression in placenta. Also found at lower
CC       levels in heart, ovary, spleen, small intestine, thymus, prostate and
CC       testis. {ECO:0000269|PubMed:18230648}.
CC   -!- DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 5
CC       (ARVD5) [MIM:604400]: A congenital heart disease characterized by
CC       infiltration of adipose and fibrous tissue into the right ventricle and
CC       loss of myocardial cells, resulting in ventricular and supraventricular
CC       arrhythmias. {ECO:0000269|PubMed:18313022}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- DISEASE: Emery-Dreifuss muscular dystrophy 7, autosomal dominant
CC       (EDMD7) [MIM:614302]: A form of Emery-Dreifuss muscular dystrophy, a
CC       degenerative myopathy characterized by weakness and atrophy of muscle
CC       without involvement of the nervous system, early contractures of the
CC       elbows, Achilles tendons and spine, and cardiomyopathy associated with
CC       cardiac conduction defects. {ECO:0000269|PubMed:21391237}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Auditory neuropathy, autosomal dominant 3 (AUNA3)
CC       [MIM:619832]: A form of sensorineural hearing loss with absent or
CC       severely abnormal auditory brainstem response, in the presence of
CC       normal cochlear outer hair cell function and normal otoacoustic
CC       emissions. Auditory neuropathies result from a lesion in the area
CC       including the inner hair cells, connections between the inner hair
CC       cells and the cochlear branch of the auditory nerve, the auditory nerve
CC       itself and auditory pathways of the brainstem. Affected individuals
CC       typically respond to sound but have difficulties in speech
CC       discrimination. AUNA3 is a late-onset, progressive form.
CC       {ECO:0000269|PubMed:34050020}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TMEM43 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55396.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL136916; CAB66850.1; -; mRNA.
DR   EMBL; AY358625; AAQ88988.1; -; mRNA.
DR   EMBL; AK027466; BAB55131.1; -; mRNA.
DR   EMBL; AK027757; BAB55348.1; -; mRNA.
DR   EMBL; AK027827; BAB55396.1; ALT_INIT; mRNA.
DR   EMBL; AK027877; BAB55425.1; -; mRNA.
DR   EMBL; AK075010; BAC11350.1; -; mRNA.
DR   EMBL; BC003125; AAH03125.1; -; mRNA.
DR   EMBL; BC008054; AAH08054.2; -; mRNA.
DR   EMBL; BC011719; AAH11719.1; -; mRNA.
DR   CCDS; CCDS2618.1; -.
DR   RefSeq; NP_077310.1; NM_024334.3.
DR   AlphaFoldDB; Q9BTV4; -.
DR   BioGRID; 122601; 226.
DR   FunCoup; Q9BTV4; 1165.
DR   IntAct; Q9BTV4; 109.
DR   MINT; Q9BTV4; -.
DR   STRING; 9606.ENSP00000303992; -.
DR   GlyGen; Q9BTV4; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BTV4; -.
DR   PhosphoSitePlus; Q9BTV4; -.
DR   SwissPalm; Q9BTV4; -.
DR   BioMuta; TMEM43; -.
DR   DMDM; 74733151; -.
DR   CPTAC; CPTAC-1646; -.
DR   jPOST; Q9BTV4; -.
DR   MassIVE; Q9BTV4; -.
DR   PaxDb; 9606-ENSP00000303992; -.
DR   PeptideAtlas; Q9BTV4; -.
DR   ProteomicsDB; 79012; -.
DR   Pumba; Q9BTV4; -.
DR   TopDownProteomics; Q9BTV4; -.
DR   Antibodypedia; 10951; 127 antibodies from 23 providers.
DR   DNASU; 79188; -.
DR   Ensembl; ENST00000306077.5; ENSP00000303992.5; ENSG00000170876.9.
DR   GeneID; 79188; -.
DR   KEGG; hsa:79188; -.
DR   MANE-Select; ENST00000306077.5; ENSP00000303992.5; NM_024334.3; NP_077310.1.
DR   UCSC; uc003byk.3; human.
DR   AGR; HGNC:28472; -.
DR   CTD; 79188; -.
DR   DisGeNET; 79188; -.
DR   GeneCards; TMEM43; -.
DR   GeneReviews; TMEM43; -.
DR   HGNC; HGNC:28472; TMEM43.
DR   HPA; ENSG00000170876; Low tissue specificity.
DR   MalaCards; TMEM43; -.
DR   MIM; 604400; phenotype.
DR   MIM; 612048; gene.
DR   MIM; 614302; phenotype.
DR   MIM; 619832; phenotype.
DR   OpenTargets; ENSG00000170876; -.
DR   Orphanet; 98853; Autosomal dominant Emery-Dreifuss muscular dystrophy.
DR   Orphanet; 293888; Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant.
DR   Orphanet; 293910; Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant.
DR   Orphanet; 293899; Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant.
DR   VEuPathDB; HostDB:ENSG00000170876; -.
DR   eggNOG; ENOG502QSR2; Eukaryota.
DR   GeneTree; ENSGT00390000009671; -.
DR   HOGENOM; CLU_042602_1_0_1; -.
DR   InParanoid; Q9BTV4; -.
DR   OMA; NMMALDE; -.
DR   OrthoDB; 410725at2759; -.
DR   PAN-GO; Q9BTV4; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9BTV4; -.
DR   PathwayCommons; Q9BTV4; -.
DR   SignaLink; Q9BTV4; -.
DR   BioGRID-ORCS; 79188; 6 hits in 1153 CRISPR screens.
DR   ChiTaRS; TMEM43; human.
DR   GeneWiki; TMEM43; -.
DR   GenomeRNAi; 79188; -.
DR   Pharos; Q9BTV4; Tbio.
DR   PRO; PR:Q9BTV4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9BTV4; protein.
DR   Bgee; ENSG00000170876; Expressed in descending thoracic aorta and 196 other cell types or tissues.
DR   ExpressionAtlas; Q9BTV4; baseline and differential.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:LIFEdb.
DR   GO; GO:0005637; C:nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006629; P:lipid metabolic process; IBA:GO_Central.
DR   GO; GO:0071763; P:nuclear membrane organization; IDA:MGI.
DR   InterPro; IPR012430; TMEM43_fam.
DR   PANTHER; PTHR13416; -; 1.
DR   PANTHER; PTHR13416:SF2; TRANSMEMBRANE PROTEIN 43; 1.
DR   Pfam; PF07787; TMEM43; 1.
DR   neXtProt; NX_Q9BTV4; -.
DR   PharmGKB; PA134871907; -.
DR   TreeFam; TF324718; -.
PE   1: Evidence at protein level;
KW   Acetylation; Cardiomyopathy; Cell membrane; Deafness; Disease variant;
KW   Emery-Dreifuss muscular dystrophy; Endoplasmic reticulum; Immunity;
KW   Innate immunity; Membrane; Neuropathy; Non-syndromic deafness; Nucleus;
KW   Proteomics identification; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..400
FT                   /note="Transmembrane protein 43"
FT                   /id="PRO_0000284498"
FT   TOPO_DOM        2..31
FT                   /note="Nuclear"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        32..52
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        53..313
FT                   /note="Perinuclear space"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        314..334
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        335..345
FT                   /note="Nuclear"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        346..366
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        367..368
FT                   /note="Perinuclear space"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        369..389
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        390..400
FT                   /note="Nuclear"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:25732826,
FT                   ECO:0007744|PubMed:19413330"
FT   VARIANT         85
FT                   /note="E -> K (in EDMD7; the mutant protein forms
FT                   predominantly monomers with very few dimers indicating a
FT                   defect in oligomerization; overexpression in HeLa cells
FT                   results in abnormal nuclear structures and decreased
FT                   nuclear localization of both EMD and SUN2 with
FT                   mislocalization of EMD to the endoplasmic reticulum;
FT                   dbSNP:rs397514044)"
FT                   /evidence="ECO:0000269|PubMed:21391237"
FT                   /id="VAR_069794"
FT   VARIANT         91
FT                   /note="I -> V (in EDMD7; the mutant protein is able to form
FT                   oligomers; overexpression in HeLa cells results in abnormal
FT                   nuclear structures and decreased nuclear localization of
FT                   both EMD and SUN2 with mislocalization of EMD to the
FT                   endoplasmic reticulum; dbSNP:rs144811578)"
FT                   /evidence="ECO:0000269|PubMed:21391237"
FT                   /id="VAR_069795"
FT   VARIANT         168
FT                   /note="K -> N (in dbSNP:rs4685076)"
FT                   /evidence="ECO:0000269|PubMed:11230166,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031751"
FT   VARIANT         179
FT                   /note="M -> T (in dbSNP:rs2340917)"
FT                   /evidence="ECO:0000269|PubMed:11230166,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031752"
FT   VARIANT         233
FT                   /note="Y -> C (in dbSNP:rs35924492)"
FT                   /id="VAR_031753"
FT   VARIANT         318
FT                   /note="A -> V (in dbSNP:rs11924644)"
FT                   /id="VAR_031754"
FT   VARIANT         358
FT                   /note="S -> L (in ARVD5; dbSNP:rs63750743)"
FT                   /evidence="ECO:0000269|PubMed:18313022"
FT                   /id="VAR_044438"
FT   VARIANT         372..400
FT                   /note="Missing (in AUNA3; decreased protein stability;
FT                   reduced passive conductance current in cochlear glia-like
FT                   supporting cells; does not affect interactions with GJB2
FT                   and GJB4; dbSNP:rs773224617)"
FT                   /evidence="ECO:0000269|PubMed:34050020"
FT                   /id="VAR_087154"
FT   CONFLICT        196
FT                   /note="L -> P (in Ref. 4; BAC11350)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        338
FT                   /note="P -> L (in Ref. 5; AAH11719)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   400 AA;  44876 MW;  70FDDD4ED1AA11DF CRC64;
     MAANYSSTST RREHVKVKTS SQPGFLERLS ETSGGMFVGL MAFLLSFYLI FTNEGRALKT
     ATSLAEGLSL VVSPDSIHSV APENEGRLVH IIGALRTSKL LSDPNYGVHL PAVKLRRHVE
     MYQWVETEES REYTEDGQVK KETRYSYNTE WRSEIINSKN FDREIGHKNP SAMAVESFMA
     TAPFVQIGRF FLSSGLIDKV DNFKSLSLSK LEDPHVDIIR RGDFFYHSEN PKYPEVGDLR
     VSFSYAGLSG DDPDLGPAHV VTVIARQRGD QLVPFSTKSG DTLLLLHHGD FSAEEVFHRE
     LRSNSMKTWG LRAAGWMAMF MGLNLMTRIL YTLVDWFPVF RDLVNIGLKA FAFCVATSLT
     LLTVAAGWLF YRPLWALLIA GLALVPILVA RTRVPAKKLE
//
